These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33606496)

  • 21. The Pandemic beyond the Pandemic: A Scoping Review on the Social Relationships between COVID-19 and Antimicrobial Resistance.
    Toro-Alzate L; Hofstraat K; de Vries DH
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?
    Pelfrene E; Botgros R; Cavaleri M
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):21. PubMed ID: 33514424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ​US Tropical Disease Priority Review Vouchers: Lessons In Promoting Drug Development And Access.
    Ridley DB; Ganapathy P; Kettler HE
    Health Aff (Millwood); 2021 Aug; 40(8):1243-1251. PubMed ID: 34339239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement.
    Berman D; Chandy SJ; Cansdell O; Moodley K; Veeraraghavan B; Essack SY
    Lancet Glob Health; 2022 Feb; 10(2):e293-e297. PubMed ID: 34914900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    Khouja T; Mitsantisuk K; Tadrous M; Suda KJ
    J Antimicrob Chemother; 2022 Apr; 77(5):1491-1499. PubMed ID: 35178565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications.
    Luepke KH; Suda KJ; Boucher H; Russo RL; Bonney MW; Hunt TD; Mohr JF
    Pharmacotherapy; 2017 Jan; 37(1):71-84. PubMed ID: 27859453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing COVID-19 within and across health systems: why we need performance intelligence to coordinate a global response.
    Kringos D; Carinci F; Barbazza E; Bos V; Gilmore K; Groene O; Gulácsi L; Ivankovic D; Jansen T; Johnsen SP; de Lusignan S; Mainz J; Nuti S; Klazinga N;
    Health Res Policy Syst; 2020 Jul; 18(1):80. PubMed ID: 32664985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tackling antimicrobial resistance in the COVID-19 pandemic.
    Getahun H; Smith I; Trivedi K; Paulin S; Balkhy HH
    Bull World Health Organ; 2020 Jul; 98(7):442-442A. PubMed ID: 32742026
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam.
    Nguyen KV; Thi Do NT; Chandna A; Nguyen TV; Pham CV; Doan PM; Nguyen AQ; Thi Nguyen CK; Larsson M; Escalante S; Olowokure B; Laxminarayan R; Gelband H; Horby P; Thi Ngo HB; Hoang MT; Farrar J; Hien TT; Wertheim HF
    BMC Public Health; 2013 Dec; 13():1158. PubMed ID: 24325208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gaps in the implementation of COVID-19 mitigation measures could lead to development of new strains of antimicrobial resistant pathogens: Nigerian perspective.
    Yusuf I; Sarkinfada F
    Pan Afr Med J; 2021; 40():12. PubMed ID: 34733380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic.
    Cantón R; Gijón D; Ruiz-Garbajosa P
    Curr Opin Crit Care; 2020 Oct; 26(5):433-441. PubMed ID: 32739970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance: the good, the bad, and the ugly.
    Hardie KR
    Emerg Top Life Sci; 2020 Sep; 4(2):129-136. PubMed ID: 32463087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial Resistance: The Next Probable Pandemic.
    Gautam A
    JNMA J Nepal Med Assoc; 2022 Feb; 60(246):225-228. PubMed ID: 35210634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial resistance and COVID-19: Intersections and implications.
    Knight GM; Glover RE; McQuaid CF; Olaru ID; Gallandat K; Leclerc QJ; Fuller NM; Willcocks SJ; Hasan R; van Kleef E; Chandler CI
    Elife; 2021 Feb; 10():. PubMed ID: 33588991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The need for holistic, longitudinal and comparable, real-time assessment of the emotional, behavioral and societal impact of the COVID-19 pandemic across nations.
    Agorastos A; Tsamakis K; Solmi M; Correll CU; Bozikas VP
    Psychiatriki; 2021 Apr; 32(1):15-18. PubMed ID: 33759804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Government policy interventions to reduce human antimicrobial use: protocol for a systematic review and meta-analysis.
    Rogers Van Katwyk S; Grimshaw JM; Mendelson M; Taljaard M; Hoffman SJ
    Syst Rev; 2017 Dec; 6(1):256. PubMed ID: 29237496
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.